BIF – Client Quarterly Update

BIF – Quarterly Client Update – 31 March 2022

14 April 2022

Booster Investment Management Limited as Manager of the Fund (the Manager), has provided a copy of
the Quarterly Client Update for the quarter ended 31 March 2022.

For further information regarding the Booster Innovation Fund visit
www.booster.co.nz/booster-
investments/booster-innovation-fund




For more information, please contact:
Gary Scott
Company Secretary
Booster Investment Management Limited
04 8944300


About Booster
Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of
the Booster Group which has been helping New Zealanders save since 1998. The group currently
administers superannuation and investment funds of over $5 billion on behalf of more than 170,000 New
Zealanders.
BIF is a managed investment fund that invests in early-stage companies founded on intellectual property
originated or developed in New Zealand.
For more information, including a copy of the Product Disclosure Statement and the net asset value per
unit, please visit
www.booster.co.nz

Booster Innovation Scheme
Booster Innovation Fund

Update as at 31 March 2022

1
v
Portfolio Performance
The Booster Innovation Fund (BIF) has had a steady quarter, returning
5.8% to March 2022 and 23% since inception (after fees and before tax).
There have been valuation movements in several companies, with the
majority of these experiencing uplifts in response to their business and
investment activities and two adjusted downwards to reflect slower than
expected progress.
As at the end of March, the Booster Innovation Fund has equity related
assets and cash exceeding $7.5m.
Portfolio Spotlight
The Fund holds units in Insitugen, a developer of anti-doping testing
solutions to detect performance enhancing drug use in animals and
humans.
During the quarter, InsituGen announced a strategic partnership with
Swiss-based Berlinger, a global market leader in doping control
equipment. The multi-year partnership includes a global distribution
agreement to supply their drug testing platform to Berlinger’s global
customers. This is an important milestone for InsituGen and an
important step towards achieving the goal of clean sport.

Portfolio Additions
During the quarter, BIF invested $1.6m and secured interests in four new
assets, Biolumic Inc, TasmanIon Ltd, Allegro Energy Pty Ltd and Montoux
Ltd and invested $0.2m in existing holdings Amaroq Ltd and XFrame Pty
Ltd. Biolumic, develop UV light systems to improve disease resistance
and yield of plant crops, TasmanIon and Allegro Energy are developing
clean and green energy storage solutions and Montoux, sell enterprise
software that combines data science expertise with machine learning to
provide actuarial automation and decision support for life and health
insurers.



Key Facts

Risk Level
Early stage company investing is generally considered the riskiest type of
equity investing. While the fund is not required to calculate a Risk
Indicator based on the volatility of the fund (being the extent to which
the fund’s assets go up and down), we consider the fund’s risk rating
would equate to 7 on a scale of 1 (low) to 7 (high). For a full description
of the risks, please read the Product Disclosure Statement.











All figures are after fees. Please see the Product Disclosure Statement
for further details.
After tax return is higher than before tax due to tax credits from
performance based fees.
1
Past performance is not an indicator of future performance.







Fund Size
(net asset value)
$7.5 million
Inception Date 24/08/2021
Manager Booster Investment Management Limited
Supervisor Public Trust
Fund Type Portfolio Investment Entity (PIE)

Performance as at 31 March 2022
1

Before Tax
After Tax
at 28%
Last month 1.9% 1.9%
Last 3 months 5.8% 6.1%
Last 6 months 22.9% 24.3%
Since Inception 24/8/21 (p.a.) 23.0% 24.4%

Booster Innovation Scheme
Booster Innovation Fund

Update as at 31 March 2022

The Booster Innovation Fund (fund) is part of the Booster Innovation Scheme which is issued and managed by Booster Investment Management Ltd (Booster). The fund’s product Disclosure
Statement is available at
www.booster.co.nz, by contacting your financial adviser or by calling Booster on 0800 40 40 50.

Disclaimer: This document is for information purposes only. The information is derived from sources believed to be accurate as at the date of issue and may change. The content is of a general
nature and does not take into account your financial situation or goals and is not financial advice. Booster, its related com panies, directors, board members and nominees do not accept any
liability for any loss or damage arising directly or indirectly out of the use of, or reliance on, the information provided in this document, nor do they guarantee the fund’s performance, returns
or repayment of capital.
2

v
BIF Investment Holdings
BIF holds interests in a portfolio of 19 investments with a total value of
$7.5m, across a range of business sectors as follows. We intend to
grow a more diversified portfolio, indicatively more than 40.
Part of the fund’s investments are held by investing in NZ Innovation
Booser LP (NZIB). For further information of how we invest through
NZIB refer to the Product Disclosure Statement on the booster.co.nz
website.

Description of Individual Holdings
Alimetry Ltd Developing devices for aiding informed diagnostics
for gastric disease.
Allegro Energy Pty Ltd High performance water-based electrolytes
provide a low cost, clean and green energy storage
solution
Amaroq Therapeutics
Ltd
Developing a new class of therapeutics that target
long non-coding RNA in cancer.
Avalia
Immunotherapies Ltd
Developing vaccines that have the potential to
treat chronic hepatitis B and cancers.
Chitogel Ltd Providing sinus dressings that helps to enhance
wound healing and improve patient outcomes
post-surgery.
Biolumic Inc Improves crop yield and quality by treating seeds
and seedlings with UV-light recipes.
Codify Assets
Solutions Ltd
Developing software that automates compliance,
management, and auditing of infrastructure assets.
Ferronova Pty Ltd Developing surgical tracer systems that are
designed to more accurately map cancer spread to
lymph nodes.
Inhibit Coatings Ltd Developing coatings to inhibit microbial
contamination and outbreaks in facilities with high
hygiene requirements.
InsituGen Ltd Developing testing solutions for the detection of
performance enhancing drug use in animals and
humans.
Jaipuna Ltd
(trading as Amy AI)
Providing an online private tutor for maths that
makes learning maths easy for everyone.
Ligar Ltd Partnership Developing solutions for highly-selective capture
and extraction of molecules for use in medicine,
flavours or nutraceuticals.
Marama Labs Ltd Providing meaningful data to help wineries
improve the quality of their wine production.
Mekonos Inc Developing silicon chips, with hundreds of moving
nano-needles, to help improve drug development
and drug delivery to patients.
Montoux Ltd Actuarial and data science expertise combined
with automation and machine learning to provide
an actuarial automation and decision support for
life and health insurers.
PowerON Ltd Developing soft robotic components to enable the
development of more lifelike robots.
Sensor Holdings Ltd
(trading as Stretch
Sense)
Providing motion capture gloves that combine
sensors and machine learning for finger tracking in
animation and gaming.
TasmanIon Ltd Aluminium-ion battery technologies suited for grid
storage and portable applications
XFrame Pty Ltd Providing recoverable, reusable building frames for
sustainable construction.

For more information visit “The BIF Story” at our website.